ACADIA Pharmaceuticals(us:ACAD)
17.16
+1.72%
Updated on 2024-12-23
Open:16.86
Close:17.16
High:17.19
Low:16.62
Pre Close:16.87
Volume:529357.00
Amount:8.97M
Turnover:0.32%
Shares:166.39M
MarketCap:2.85B
About ACADIA Pharmaceuticals Company
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Company Name: ACADIA Pharmaceuticals
Company Address: 12830 El Camino Real,Suite 400
Employees: 598
Fiscar Year: 12-31
IPO Date: 2004-05-27
Website: http://www.acadia.com
CIK: 1070494
View all SEC Filings
About
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Address:12830 El Camino Real,Suite 400
Website:http://www.acadia.com
Market Movers